For single gene or tumor phenotype biomarker, microsatellite instability (MSI) high is a validated prognostic biomarker in early stage colorectal cancer while the prognostic value of BRAF or KRAS mutation depends on microsatellite status and tumor location7. The gene discussed is KRAS; the disease is neoplasm.